DECITABINE + CEDAZURIDINE

decitabine 35 mg + cedazuridine 100 mg tablet, 5

DECITABINE + CEDAZURIDINE (13081L)

decitabine 35 mg + cedazuridine 100 mg tablet, 5
13081L
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction  13258

Indication: Acute Myeloid Leukaemia
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 5 # of repeats: 5 DPMQ: $4,862.93 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Inqovi 35/100